Results 111 to 120 of about 1,314 (148)

In Vitro and In Vivo Wide-Spectrum Dual Antimycetomal Activity of Eight Essential Oils Coupled with Chemical Composition and Metabolomic Profiling [PDF]

Mycetoma, a neglected infection of subcutaneous tissues, poses a significant health burden, especially in tropical regions. It is caused by fungal (eumycetoma) and bacterial (actinomycetoma) pathogens, with current treatments often providing ...
Abd Algaffar, Shereen O., Ashmawy, Naglaa S., Khalid, Sami A., Satyal, Prabodh, van de Sande, Wendy W. J., Verbon, Annelies   +5 more
core   +2 more sources

Development and Validation of an In Vitro Resazurin-Based Susceptibility Assay against Madurella mycetomatis. [PDF]

Antimicrob Agents Chemother, 2021
Abd Algaffar SO, Verbon A, van de Sande WWJ, Khalid SA.   +3 more
europepmc   +1 more source

Comparison of Disc Diffusion, Etest, and a Modified CLSI Broth Microdilution Method for In Vitro Susceptibility Testing of Itraconazole, Posaconazole, and Voriconazole against Madurella mycetomatis. [PDF]

Antimicrob Agents Chemother, 2021
Nyuykonge B, van Amelsvoort L, Eadie K, Fahal AH, Verbon A, van de Sande W.   +5 more
europepmc   +1 more source

Subcutaneous facial mycosis in a child due to Madurella mycetomatis.

JPMA. The Journal of the Pakistan Medical Association, 2008
Mycetoma is a chronic, granulomatous, subcutaneous, inflammatory disease caused by true fungi (eumycetoma) or filamentous bacteria (actinomycetoma). Eumycetoma usually affects adult males involving limbs and other exposed body parts. Children represent the least commonly encountered age group with this disease. A case of subcutaneous facial mycosis due
Sajjad Hussain, Mirza, Adeel Hussain, Gardezi, Yaseen, Khan, M Ameen, Wiqar   +3 more
openaire   +1 more source

Eumycetoma versus actinomycetoma: Diagnosis on cytology

Journal of Cytology, 2010
Eumycetoma is a chronic cutaneous and subcutaneous infection caused by various genera of fungi producing specific colored granules known as grains. A 45-year-old farmer presented clinically with a left foot mass with multiple discharging sinuses existing
Afroz Nishat, Khan Nazoora, Siddiqui Farhan, Rizvi Mehar   +3 more
doaj  

Structure-activity relationships of fenarimol analogues with potent <i>in vitro</i> and <i>in vivo</i> activity against <i>Madurella mycetomatis</i>, the main causative agent of mycetoma. [PDF]

RSC Med Chem
Duong HP, Melechov D, Lim W, Ma J, Scroggie KR, Rajendra L, Perry B, Cruz LR, Saleem RSZ, Rutledge PJ, Motion A, van de Sande WWJ, Todd MH.   +12 more
europepmc   +1 more source

Madurella mycetomatis infection of the foot: a case report of a neglected tropical disease in a non-endemic region. [PDF]

BMC Dermatol, 2020
Karrakchou B, Boubnane I, Senouci K, Hassam B.   +3 more
europepmc   +1 more source

In Situ Hybridization for Madurella mycetomatis using Madurella specific probe [PDF]

, 2018
openaire   +1 more source

Erratum for Abd Algaffar et al., "Development and Validation of an In Vitro Resazurin-Based Susceptibility Assay against Madurella mycetomatis". [PDF]

Antimicrob Agents Chemother
Abd Algaffar SO, Verbon A, van de Sande WWJ, Khalid SA.   +3 more
europepmc   +1 more source

Iron regulatory pathways differentially expressed duringMadurella mycetomatisgrain development inGalleria mellonella

, 2022
Abugessaisa I, Konings M, Manabe R, Kawashima T, Hasegawa A, Takahashi C, Tagami M, Okazaki Y, Lim W, Verbon A, Fahal AH, Kasukawa T, van de Sande WW.   +12 more
europepmc   +1 more source